Freeze & boost: new combo aims to stop aggressive breast Cancer's return

NCT ID NCT03546686

Recruiting now Disease control Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

Summary

This study is testing if freezing a tumor (cryoablation) followed by an immunotherapy drug (pembrolizumab) before surgery can help prevent cancer from coming back in women with a hard-to-treat type called triple-negative breast cancer. It's for women who still have cancer after initial chemotherapy. The goal is to see if this two-step approach helps patients live longer without their cancer progressing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cedars Sinai Medical Center
ACTIVE_NOT_RECRUITING

Los Angeles, California, 90048, United States
Ohio State University Medical Center
COMPLETED

Columbus, Ohio, 43210, United States
Providence Cancer Institute
ACTIVE_NOT_RECRUITING

Portland, Oregon, 97213, United States
UT Southwestern Medical Center
RECRUITING

Dallas, Texas, 75390, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BREAST CANCER